| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112492A Diagnosis and treatment of cancer using anti-GPR49 antibody |
| 06/29/2011 | CN102112478A 5H-pyrr0l0 [2, 3-B] pyrazine derivatives for kinase modulation, and indications therefor |
| 06/29/2011 | CN102112468A New compounds |
| 06/29/2011 | CN102112463A 5-substituted isoindoline compounds |
| 06/29/2011 | CN102112445A Hydroxyphenylsulfonamides as antiapoptotic Bcl inhibitors |
| 06/29/2011 | CN102112146A Immunity inducer |
| 06/29/2011 | CN102112145A Suppression of neuroendocrine diseases |
| 06/29/2011 | CN102112141A Composition useful for prevention or reduction of progression of prostate cancer |
| 06/29/2011 | CN102112138A Anti-tumor agent |
| 06/29/2011 | CN102112136A Composition for inhibiting expression of target gene |
| 06/29/2011 | CN102112133A Pharmaceutical uses of lanosta-8, 24-dien-3-ols |
| 06/29/2011 | CN102112129A Thiazole compounds, and compositions and methods using same |
| 06/29/2011 | CN102112110A Novel compositions for the in vivo delivery of RNAi agents |
| 06/29/2011 | CN102108372A Preparation method and application of beta-glucan |
| 06/29/2011 | CN102108369A Application of DNA repair protein RAD51 in preparing medicament for treating osteosarcoma |
| 06/29/2011 | CN102108356A Novel promoter and virus vector containing same |
| 06/29/2011 | CN102108350A Preparation method of bromelin |
| 06/29/2011 | CN102108336A Recombinant adenovirus vaccine containing EB (Epstein-Barr) virus membrane protein gp350/220, gp85, gp78 or gp25 gene |
| 06/29/2011 | CN102108092A 23-hydroxy betulinic acid derivative as well as preparation method and application thereof |
| 06/29/2011 | CN102108083A Polycyclic benzopyrone compounds and preparation method and application thereof |
| 06/29/2011 | CN102108079A 4-anilino quinazoline derivatives serving as tyrosine kinase inhibitors |
| 06/29/2011 | CN102108078A 1,4-substituted phthalazine compound and preparation method and applications thereof |
| 06/29/2011 | CN102108075A Method for synthesizing novel derivatives from gibberellane GA3 and use thereof |
| 06/29/2011 | CN102107011A Paramagnetic-upconversion luminous composite nanometer particle, preparation method and application thereof |
| 06/29/2011 | CN102107009A Mixed compound medicament of natural medicament components and nitric oxide donors and application thereof |
| 06/29/2011 | CN102107008A DNA damage repair inhibitors for treatment of cancer |
| 06/29/2011 | CN102106991A Medicament for treating moderate/advanced liver cancer chemoembolization |
| 06/29/2011 | CN102106987A Preparation method of Chinese medicine for treating cancer |
| 06/29/2011 | CN102106966A Preparation method of Chinese medicinal composition with functions of supplementing qi and nourishing blood |
| 06/29/2011 | CN102106962A Chinese medicinal composition for treating gastric cancer |
| 06/29/2011 | CN102106953A Chinese medicine oral decoction for treating esophagus cancer |
| 06/29/2011 | CN102106944A Application of palmate pinellia tuber protein in treatment of cervical carcinoma and preparation thereof |
| 06/29/2011 | CN102106928A Method for preparing high-purity oil tea saponins |
| 06/29/2011 | CN102106909A Fuzheng Zengxiao Anti-cancer Chinese herbal medicine and preparation method thereof |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106872A Crocodile blood freeze-dried powder, and preparation method and application thereof |
| 06/29/2011 | CN102106866A Pharmaceutical composition and preparation method thereof |
| 06/29/2011 | CN102106864A Application of icariin for preparing medicament for resisting myeloid-derived suppressor cells (MDSCs) |
| 06/29/2011 | CN102106861A Anti-colon cancer effect of maslinic acid and medicinal preparation thereof |
| 06/29/2011 | CN102106860A Anti-liver-cancer effect of Oleanolic acid and pharmaceutic preparation |
| 06/29/2011 | CN102106859A Breast cancer-resisting function and pharmaceutical preparation of maslinic acid |
| 06/29/2011 | CN102106858A Anti-cervical carcinoma effect of maslinic acid and medicinal preparation thereof |
| 06/29/2011 | CN102106851A Application of brusatol as chemotherapeutic drug synergist |
| 06/29/2011 | CN102106848A Pharmaceutical composition for treating non-small cell lung cancer (NSCLC) and application thereof, kit and package part |
| 06/29/2011 | CN102106847A New fat soluble platinum injection preparation as well as preparation method and applications thereof |
| 06/29/2011 | CN102106845A Medicinal application of 4-methyl-3-nitrobenzoic acid |
| 06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
| 06/29/2011 | CN102106833A Pemetrexed disodium freeze-dried powder injection and preparation method thereof |
| 06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
| 06/29/2011 | CN102106818A Isoliquiritigenin micro-emulsion composition |
| 06/29/2011 | CN102106816A Resveratrol nanometer preparation and preparation method thereof |
| 06/29/2011 | CN102106420A Method for processing camellia nitidissima granules |
| 06/29/2011 | CN101869692B Curcumin self-microemulsion and preparation method thereof |
| 06/29/2011 | CN101716346B Supramolecular hydrogel gene vector material, and preparation method and application thereof |
| 06/29/2011 | CN101711777B Method for removing pesticide residue in production process of lucid ganoderma extract |
| 06/29/2011 | CN101647793B Application of anacardic acid in preparing anti-angiogenic drugs |
| 06/29/2011 | CN101632636B Taxol lipid preparation and method for preparing same |
| 06/29/2011 | CN101627969B Novel curcumin self-emulsifying drug delivery system and preparation method thereof |
| 06/29/2011 | CN101580525B Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs |
| 06/29/2011 | CN101530420B Application of tunicamycin in preparing tumour cell reversing drug |
| 06/29/2011 | CN101485887B 5-fluorouracil-sn2-phosphatidyl choline copolymer as well as preparation method and application thereof |
| 06/29/2011 | CN101463074B Method for synthesizing cell toxic alkaloid and epimer thereof |
| 06/29/2011 | CN101450165B Anti-cancer traditional Chinese medicine compound ganoderma preparation and preparation method thereof |
| 06/29/2011 | CN101450132B Medicine for treating cancer |
| 06/29/2011 | CN101440126B Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 06/29/2011 | CN101396563B Chitose derivates using octreotide as target ligand and use thereof in medicament |
| 06/29/2011 | CN101386629B Water-soluble Pt(II) anticancer complexes using 3-acetoxy-1,1-cyclobutane dicarboxylic acid radical as leaving group |
| 06/29/2011 | CN101368187B Recombinant human FUS1 and human IL-12 dual-gene expression carrier, liposome complexes, preparation method and application thereof |
| 06/29/2011 | CN101333238B Triterpene compounds separated from seed of cowherb of Chinese traditional medicine and uses thereof |
| 06/29/2011 | CN101321532B Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis |
| 06/29/2011 | CN101306183B Common turmeric extract fat emulsion injection and its preparation method and use |
| 06/29/2011 | CN101306181B Elemene fat emulsion injection and preparation method thereof |
| 06/29/2011 | CN101254269B Cancer treating medical composition, preparation and uses thereof |
| 06/29/2011 | CN101001834B Nonpeptide inhibitors of matrix metalloproteinases |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968688 Antibodies that bind to the C35 polypeptide |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968586 Cytotoxic compounds and conjugates |
| 06/28/2011 | US7968581 Imidazolidine compounds as androgen receptor modulators |
| 06/28/2011 | US7968566 Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors |
| 06/28/2011 | US7968563 Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| 06/28/2011 | US7968560 Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 06/28/2011 | US7968559 Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
| 06/28/2011 | US7968557 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 06/28/2011 | US7968554 Pyrazolo[3,4-d]pyrimidine derivatives |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968546 Pyridazinone kinase inhibitors |
| 06/28/2011 | US7968531 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968333 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 06/28/2011 | US7968332 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 06/28/2011 | US7968307 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2011 | US7968303 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1) |
| 06/28/2011 | US7968103 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 06/28/2011 | US7968099 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 06/28/2011 | US7968093 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 06/28/2011 | CA2512608C (2-carboxamido)(3-amino) thiophene compounds |
| 06/28/2011 | CA2464002C Pacap compositions and methods for tumor imaging and therapy |